Literature DB >> 15452896

Anticipating loss and other temporal stressors predict traumatic stress symptoms among partners of metastatic/recurrent breast cancer patients.

Lisa D Butler1, Nigel P Field, Amy L Busch, Julie E Seplaki, T Andrew Hastings, David Spiegel.   

Abstract

This study examined pre- and post-loss levels of posttraumatic stress symptoms (intrusion and avoidance) in partners of metastatic/recurrent breast cancer patients, and the relationship of these symptoms to past, current, and anticipatory stressors. The results indicate that 34% (17/50) of the partners experienced clinically significant symptom levels prior to the patients' deaths. Prior to loss, partners' symptoms were positively associated with their current level of perceived stress and anticipated impact of the loss; whereas following loss, partners' symptoms were predicted by higher pre-loss levels of symptoms, past family deaths, and anticipated impact of the loss. Limitations and treatment implications of the present research and directions for future research are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15452896     DOI: 10.1002/pon.865

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  10 in total

Review 1.  Physical, psychosocial, relationship, and economic burden of caring for people with cancer: a review.

Authors:  Afaf Girgis; Sylvie Lambert; Claire Johnson; Amy Waller; David Currow
Journal:  J Oncol Pract       Date:  2012-12-04       Impact factor: 3.840

2.  Patient and spouse illness beliefs and quality of life in prostate cancer patients.

Authors:  Lisa M Wu; Nihal E Mohamed; Gary Winkel; Michael A Diefenbach
Journal:  Psychol Health       Date:  2012-09-13

3.  A partnership in like-minded thinking-generating hopefulness in persons with cancer.

Authors:  Tressie A Dutchyn Ayers
Journal:  Med Health Care Philos       Date:  2006-08-04

4.  Cancer as a Criterion A Traumatic Stressor for Veterans: Prevalence and Correlates.

Authors:  Elizabeth A Mulligan; Jennifer Schuster Wachen; Aanand D Naik; Jeffrey Gosian; Jennifer Moye
Journal:  Psychol Trauma       Date:  2014

5.  Providing general practice needs-based care for carers of people with advanced cancer: a randomised controlled trial.

Authors:  Geoffrey K Mitchell; Afaf Girgis; Moyez Jiwa; David Sibbritt; Letitia H Burridge; Hugh E Senior
Journal:  Br J Gen Pract       Date:  2013-10       Impact factor: 5.386

6.  A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer.

Authors:  Oxana Gronskaya Palesh; Kate Collie; Daniel Batiuchok; Jackie Tilston; Cheryl Koopman; Michael L Perlis; Lisa D Butler; Robert Carlson; David Spiegel
Journal:  Biol Psychol       Date:  2006-12-12       Impact factor: 3.251

7.  Relationship Between Post-traumatic Stress Symptoms and Anticipatory Grief in Family Caregivers of Patients With Advanced Lung Cancer: The Mediation Role of Illness Uncertainty.

Authors:  Di Sun; Zhihui Mao; Xu Zhang; Jiaojiao Li; Lijuan Zhang
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

8.  A GP Caregiver Needs Toolkit versus usual care in the management of the needs of caregivers of patients with advanced cancer: a randomized controlled trial.

Authors:  Geoffrey Mitchell; Afaf Girgis; Moyez Jiwa; David Sibbritt; Letitia Burridge
Journal:  Trials       Date:  2010-11-29       Impact factor: 2.279

9.  A comparison of psychological well-being and quality of life between spouse and non-spouse caregivers in patients with head and neck cancer: a 6-month follow-up study.

Authors:  Yu Lee; Pao-Yen Lin; Chih-Yen Chien; Fu-Min Fang; Liang-Jen Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-28       Impact factor: 2.570

10.  Development of a home-visit nursing scale for helping spousal caregivers of terminal cancer patients develop positive perspectives of their caregiving experiences: a cross-sectional study.

Authors:  Mari Karikawa; Hisae Nakatani
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.